The top 3 sought-after skills when Australia employers hire offshore talent: IT (38%), General Admin (30%) and R&D, such as highly skilled scientists or engineers or researchers (24%) The top 3 preferred locations Australia employers' source for offshore talent are: Singapore (42%), Malaysia (27%) and India (20%) 84% of employers across Asia Pacific favour offshoring recruitment strategies. Markets with the highest adoption rate are Vietnam (46%), South Korea (43%), Thailand (39%) SINGAPORE, Nov. 1, 2022 /PRNewswire/ PERSOLKELLY, one of Asia Pacific's leading HR solutions companies, has conducted a business survey among 1,326 decision-makers who are responsible for hiring within their organisation, and the report titled "Hiring and Managing Talent Beyond Geographical Boundaries" highlighted the effectiveness and the growing trend of employers across the region in adopting offshore recruitment strategies for their hiring needs. Having become more open to adopting
BEIJING, Nov. 1, 2022 /PRNewswire/ China and Vietnam agreed on Monday to strengthen strategic communication, enhance political mutual trust, properly manage differences in a bid to bring their comprehensive strategic cooperative partnership in the new era to a new level as Chinese top leader met Nguyen Phu Trong, general secretary of the Communist Party of Vietnam (CPV) Central Committee in Beijing. Xi Jinping, general secretary of the Communist Party of China (CPC) Central Committee and Chinese president, welcomed Nguyen Phu Trong, general secretary of the CPV Central Committee at the Great Hall of the People in Beijing on Monday. The two leaders witnessed the signing of a batch of cooperation papers in multiple fields, which analysts said reflected the high level of political trust and laid the foundation for further deepening of bilateral relations in the future amid a more complicated international environment. During their meeting, Xi said that Nguyen was the first foreign leader
SAN FRANCISCO, HOUSTON and SINGAPORE, Nov. 1, 2022 /PRNewswire/ Hummingbird Bioscience, a data-driven precision biotherapeutics company discovering and developing transformative biologic medicines for hard-to-treat diseases, today announced that Chief Financial Officer Josh House and Chief Development Officer Leah DiMascio will participate in one-on-one investor meetings at the Credit Suisse 31st Annual Global Healthcare Conference on November 7 - 10, 2022 at the Terranea Resort in Rancho Palos Verdes, CA. About Hummingbird Bioscience Hummingbird Bioscience is a data-driven precision biotherapeutics company discovering and developing transformative biologic medicines for hard-to-treat diseases. The Hummingbird Bioscience model combines computational and systems biology with wet lab drug discovery in a multi-disciplinary, collaborative environment spanning initial discovery through clinical development. We harness this integrated approach across target identification and patient selec
MANAMA, Bahrain, Nov. 1, 2022 /PRNewswire/ Bahrain's investment promotion agency, the Bahrain Economic Development Board (Bahrain EDB), announced its participation in the Singapore Fintech Festival (2-4 November) with the aim to support fintech and financial services companies tap into MENA market through Bahrain. During the first three quarters of 2022, Bahrain EDB has supported nine financial services companies to setup or expand in Bahrain, generating US$72.7 million (BHD27.5 million) in direct investments. The financial services investments are expected to generate over 840 jobs over the next three years. Financial services companies attracted by Bahrain EDB include the leading global blockchain services provider Binance, locally grown open Banking company Spier Technologies, and new regional headquarters for Gulf Insurance Group (GIG). Dalal Buhejji, Executive Director - Business Development for Financial Services at Bahrain EDB, said: "We are delighted to see more and
SINGAPORE, Nov. 1, 2022 /PRNewswire/ GenScript Biotech Corporation ("GenScript", Stock Code: 1548.HK), a leading global biotechnology company supported Chulalongkorn University, a research-intensive university in Thailand in developing human anti-SARS-CoV-2 antibodies with antibody production and characterization services. The antibodies were licensed to Hibiocy Co. Ltd., which further developed them into a nasal spray medical device named VAILL COVITRAP. The Thai FDA has approved VAILL COVITRAP as a Class 4 medical device, making Thailand the first country to approve the manufacturing of human monoclonal antibody-based COVID-19 nasal spray. The human anti-SARS-CoV-2 antibodies which area crucial part ofthe VAILL COVITRAP nasal spray device weredeveloped by Dr. Trairak Pisitkun's team from Chulalongkorn University, Bangkok, Thailand. GenScript has supported the team with antibody production and characterization during the early phase of research and contributed to the d